Last reviewed · How we verify
NCT04095377
Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.
trial testing No intervention, this is a retrospective study. in Healthy in 875 participants. Completed in 14 February 2022.
14 February 2022
Quick facts
| Lead sponsor | QuantalX Neuroscience |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 875 |
| Start date | 24 March 2019 |
| Primary completion | 14 February 2022 |
| Estimated completion | 14 February 2022 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- No intervention, this is a retrospective study.
Conditions studied
- Healthy — all drugs for Healthy →
- CVA — all drugs for CVA →
- Hemorrhage — all drugs for Hemorrhage →
- TBI (Traumatic Brain Injury) — all drugs for TBI (Traumatic Brain Injury) →
Sponsor
QuantalX Neuroscience
Who can join
18 and older, any sex, with Healthy or CVA. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
DELPhI software developed for the analysis of EEG recordings in response to magnetic stimulation in relation to clinical data.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04095377
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other QuantalX Neuroscience trials
Trials by the same sponsor.
- NCT06368024 — Establishment of Delphi-MD Safety Performance and Reliability · completed
- NCT03884647 — DELPHI in Subjects at Risk for Stroke and Dementia · completed
- NCT03832413 — Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04095377 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by QuantalX Neuroscience
- Last refreshed: 16 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04095377.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing